ALGORAE PHARMACEUTICALS LIMITED — Director's Dealing 2009

Jun 9, 2009

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity LIVING CELL TECHNOLOGIES LTD ABN 104 028 042

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	MR DAVID COLLINSON
Date of last notice	4 JUNE 2008

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

	Name of Director	Name of Director	MR DAVID COLLINSON	MR DAVID COLLINSON	MR DAVID COLLINSON	MR DAVID COLLINSON
	Date of last notice		4 JUNE 2008
Part 1 - Change of direIn the case of a trust, this in
		ctor’s relevant interests in securitiescludes interests in the trust made available by the responsible entity of			the trust
Note: In the case of a company,disclosed in this part.Direct or indirect inte		interests which come within paragraph (i) of the definition of “notifiable interes			t of a director” should be
	Direct or indirect inte	rest		DIRECT AND INDIR	ECT
	Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.			DIRECTOR OF PANCEL LIMITED
	Date of change			A) 4 MARCH 2009B) 9 MARCH 2009C) 18 MARCH 2008
	No. of securities held prior to change			149,228 ORINARY SHARES (HELD BYDAVID COLLINSON)10,149,090 ORDINARY SHARES (HELD BYDAVID AND GRAEME COLLINSON)60,494 ORDINARY SHARES (HELD BYDAVID COLLINSON, GRAEME COLLINSONAND ANNA NATHAN)2,123,300 OPTIONS EXPIRING 30/06/2010350,000 OPTIONS EXERCISABLE AT $0.30PER SHARE, VESTING ON 9 MARCH 2007AND EXPIRING ON 9 MARCH 2009104,166 ORDINARY SHARES (HELD BYPANCELL LIMITED)

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

	Class		A) ORDINARY	HARES
			B) OPTIONS
			C) ORDINARY	SHARES
	Number acquired		A) 756 SHARES
	Number disposed		B) 350,000
			C) 104,166
	Value/Consideration		A) $0.20 PER S	HARE
	Note: If consideration is non-cash, provivaluation	de details and estimated	B) $0.20 PER S	HARE
	N f iti hld ft h		149228 ORIN	RY SHARES HELD BY
	o. o secures e aer cang		,DAVID COLLIN	(SON)
			10,149,846 OR	DINARY SHARES (HELD BY
			DAVID AND GR	AEME COLLINSON)
			60,494 ORDINDAVID COLLIN	ARY SHARES (HELD BYON GRAEME COLLINSON
			AND ANNA NA	,THAN)
			2,123,300 OPTI	ONS EXPIRING 30/06/2010
	Nature of change		A) TRANSFER
	Example: on-market trade, off-market trade, esecurities under dividend reinvestment plan, pa	xercise of options, issue ofrticipation in buy-back	B LAPSED OP	IONS
			)C) OFF MARKET TRADE

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

disclosed in this part.	disclosed in this part.
	Detail of contract		N/A
	Nature of interest		N/A
	Name of registered holder(if issued securities)		N/A
	Date of change		N/A
	No and class of securities to which		N/A
	.interest related prior to change
	Note: Details are only required for a contract in relationto which the interest has changed
	Interest acquired		N/A
	Interest disposed		N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Value/ConsiderationNote: If consideration is non-cash, provide details andan estimated valuation	N/A
Interest after change	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 3

11/3/2002